🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 92346J108 (prev. 00253U305 )
- Market Cap
- Mid Cap · $850 Million
- Previous Symbol
- ASTM (changed 11/25/2014)
- Previous Name
- Aastrom Biosciences, Inc.
Business: Vericel Corp. is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American commercial rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
Notes: October 16, 2013 -- Aastrom Biosciences One-for-Twenty Reverse Stock Split.
(646) 378-2947
Company Contact
- CEO
- Dominick C Colangelo
- CFO
- Gerard J. Michel
- Headquarters
- 64 Sidney Sreet, Cambridge, MA 02139
- Phone
- 617-252-7999 · Toll-Free 800-556-0311
- Fax
- 617-252-7550
- Investor Relations
- Lee Stern. Solebury Trout · 646-378-2947 · lstern@troutgroup.com